Cancer
-
New strategy to escalate research impact and deliver world leading care
Posted on:
More than 150 people came together for the launch of the Kolling Institute’s Research Strategy 2026-2030, a roadmap to strengthen research expertise and expand access to high-value care. Developed through extensive consultation with researchers, clinicians, consumers, and partners, the strategy provides a framework to guide future growth, innovation and impact. Academic Director Professor James Elliott…
-
Internationally-recognised researchers join the Kolling
Posted on:
Our cancer and musculoskeletal expertise has been strengthened with the appointment of two senior researchers and their teams to the Kolling Institute. Professor Marina Pajic has been appointed the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research following a remarkable $11 million gift. It is the largest individual philanthropic gift to pancreatic cancer research in Australia.…
-
Innovative cancer clinical trials unit unveiled
Posted on:
Researchers from the Kolling Institute will help progress the latest cancer treatments following the official opening of an early phase clinical trials unit at Royal North Shore Hospital. The early phase unit of the NORTH STAR Van Norton Poche Cancer Trials Centre is a dedicated facility to meet the needs of patients and their carers,…
Category: Research Excellence -
2026 Beryl and Jack Jacobs Travel Awards announced
Posted on:
A collection of five early-to-mid career researchers will share close to $40,000 in funding through the Skipper Jacobs Charitable Trust. The Skipper family has generously supported emerging research talent at the Kolling Institute for many years, providing invaluable travel and career opportunities. This year’s group has welcomed the chance to travel internationally, meet with research…
-
Funds to deliver game-changing approach to cancer screening and treatment
Posted on:
Researchers at the Kolling Institute have been awarded significant funding to embed an innovative technique for cancer diagnosis and treatment into healthcare across New South Wales. Delivered by the Cancer Institute NSW, the $3.75 million Translational Program Grant has been awarded to leading clinician and University of Sydney researcher Professor Anthony Gill to test and…
-
Introducing BRIDGE: A life- changing gift advancing research and treatment for a rare form of bowel cancer
Posted on:
The University of Sydney and the Kolling Institute have launched a groundbreaking research program to transform treatment for one of the most aggressive forms of bowel cancer. Supported by a $1.3 million philanthropic gift, the BRIDGE program offers new hope for patients with BRAFv600e‑mutated bowel cancer. This mutation, present in around 10 per cent of…
Category: Research Excellence -
The Kolling welcomes Australia’s leading genomics provider to the institute
Posted on:
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility – establishing a laboratory within the institute. The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and…
-
September 2025 Kolling NEWS
Posted on:
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators. There’s an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40…
-
Game-changing blood test to detect bowel cancer
Posted on:
Bowel cancer is the third most common type of cancer in Australia and treating it is both costly and complex. Alarmingly, rates are rising among people under 50, and researchers still don’t know why. It is for these reasons that Professor Mark Molloy is on a mission to prevent the disease in the first place. Based…
Category: Research Excellence -
Podcast offers insight into the future of healthcare
Posted on:
A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney. Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute. Co-hosted by the Kolling Institute’s Academic Director Professor James Elliott and leading…
Copyright © 2026 Kolling Institute
All rights reserved